LEE TIDMAN: Open Payments
NPI 1316947260 · BLUE RIDGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,121 in 45 payments from 16 companies in 2025. Trend: 2023 $758 · 2024 $800 · 2025 $1,121
Food & beverage: $1,121
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 5 | $233 |
| Novo Nordisk Inc | 13 | $192 |
| Amgen Inc. | 6 | $186 |
| Eisai Inc. | 2 | $125 |
| ABBVIE INC. | 3 | $69 |
| Antares Pharma, Inc. | 3 | $58 |
| Lilly USA, LLC | 2 | $40 |
| Abbott Laboratories | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
Products named: Korlym, EVENITY, Leqembi, Rybelsus, XYOSTED, Ozempic, FREESTYLE LIBRE 3, CAPLYTA.
Industry payments across GA — which companies pay providers there.
